Therapies for dogs – an overview of innovative solutions from Sanford Biotech
Sanford Biotech develops modern biological therapies based on mesenchymal stem cells (MSCs), platelet-rich plasma (PRP) and molecular biology, developed in accordance with GMP, GLP and GCP standards. Our projects cover a wide range of conditions affecting dogs, from degenerative joint disease to chronic skin inflammation. All therapies are based on scientific research and are available at specialised veterinary clinics.